• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Association between comorbidity and clinical characteristics of MS.合并症与 MS 的临床特征之间的关系。
Acta Neurol Scand. 2011 Aug;124(2):135-41. doi: 10.1111/j.1600-0404.2010.01436.x. Epub 2010 Sep 29.
2
Comorbidity delays diagnosis and increases disability at diagnosis in MS.合并症会延迟多发性硬化症的诊断,并增加确诊时的残疾程度。
Neurology. 2009 Jan 13;72(2):117-24. doi: 10.1212/01.wnl.0000333252.78173.5f. Epub 2008 Oct 29.
3
Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis.血管合并症与多发性硬化症中更快的残疾进展有关。
Neurology. 2010 Mar 30;74(13):1041-7. doi: 10.1212/WNL.0b013e3181d6b125.
4
Comorbidity, socioeconomic status and multiple sclerosis.共病、社会经济地位与多发性硬化症
Mult Scler. 2008 Sep;14(8):1091-8. doi: 10.1177/1352458508092263.
5
Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosis.视觉和血管合并症与多发性硬化症患者视力障碍的显著不良关联。
Mult Scler. 2011 Dec;17(12):1464-71. doi: 10.1177/1352458511414041. Epub 2011 Aug 15.
6
Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark.多发性硬化症中的血管合并症:丹麦的一项全国性研究。
J Neurol. 2016 Dec;263(12):2484-2493. doi: 10.1007/s00415-016-8295-9. Epub 2016 Oct 3.
7
The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated.多发性硬化症中心理共病的负担:常见、诊断不足且治疗不足。
Mult Scler. 2009 Mar;15(3):385-92. doi: 10.1177/1352458508099477. Epub 2009 Jan 19.
8
Smokers with multiple sclerosis are more likely to report comorbid autoimmune diseases.多发性硬化症患者更有可能报告合并自身免疫性疾病。
Neuroepidemiology. 2011;36(2):85-90. doi: 10.1159/000323948. Epub 2011 Feb 1.
9
Vascular comorbidities in the onset and progression of multiple sclerosis.多发性硬化症发病和进展中的血管合并症。
J Neurol Sci. 2014 Dec 15;347(1-2):23-33. doi: 10.1016/j.jns.2014.10.020. Epub 2014 Oct 16.
10
Gender and autoimmune comorbidity in multiple sclerosis.多发性硬化症中的性别与自身免疫性合并症
Mult Scler. 2014 Aug;20(9):1244-51. doi: 10.1177/1352458514521515. Epub 2014 Feb 5.

引用本文的文献

1
Fatigue and its correlation with anxiety and depression in patients with multiple sclerosis in China.中国多发性硬化症患者的疲劳及其与焦虑和抑郁的相关性。
Front Neurol. 2025 Jul 7;16:1604540. doi: 10.3389/fneur.2025.1604540. eCollection 2025.
2
Comorbidity and cardiovascular risk factors in multiple sclerosis.多发性硬化症中的共病与心血管危险因素
Mult Scler J Exp Transl Clin. 2025 Jun 24;11(2):20552173251352735. doi: 10.1177/20552173251352735. eCollection 2025 Apr-Jun.
3
From Obesity to Mitochondrial Dysfunction in Peripheral Tissues and in the Central Nervous System.从外周组织和中枢神经系统中的肥胖到线粒体功能障碍
Biomolecules. 2025 Apr 29;15(5):638. doi: 10.3390/biom15050638.
4
Behavioral disorders in multiple sclerosis: a comprehensive review.多发性硬化症中的行为障碍:全面综述
J Neural Transm (Vienna). 2025 Jan;132(1):1-22. doi: 10.1007/s00702-024-02816-9. Epub 2024 Sep 4.
5
A future of AI-driven personalized care for people with multiple sclerosis.人工智能驱动的多发性硬化症患者个性化护理的未来。
Front Immunol. 2024 Aug 19;15:1446748. doi: 10.3389/fimmu.2024.1446748. eCollection 2024.
6
Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis.抑郁症状、焦虑和认知障碍:多发性硬化症中的新证据。
Transl Psychiatry. 2023 Jul 19;13(1):264. doi: 10.1038/s41398-023-02555-7.
7
Adiponectin Alleviates Cell Injury due to Cerebrospinal Fluid from Multiple Sclerosis Patients by Inhibiting Oxidative Stress and Proinflammatory Response.脂联素通过抑制氧化应激和促炎反应减轻多发性硬化症患者脑脊液所致的细胞损伤。
Biomedicines. 2023 Jun 12;11(6):1692. doi: 10.3390/biomedicines11061692.
8
High prevalence of comorbidities at diagnosis in immigrants with multiple sclerosis.多发性硬化症移民患者确诊时合并症的高患病率。
Mult Scler. 2021 Oct;27(12):1902-1913. doi: 10.1177/13524585211031791. Epub 2021 Jul 30.
9
Prevalence of Sexual Dysfunction and Related Risk Factors in Men with Multiple Sclerosis in Iran: A Multicenter Study.伊朗多发性硬化症男性性功能障碍及相关危险因素的患病率:一项多中心研究
Neurol Ther. 2021 Dec;10(2):711-726. doi: 10.1007/s40120-021-00257-0. Epub 2021 May 18.
10
Change and onset-type differences in the prevalence of comorbidities in people with multiple sclerosis.多发性硬化症患者合并症的患病率在变化和发病类型上的差异。
J Neurol. 2021 Feb;268(2):602-612. doi: 10.1007/s00415-020-10194-x. Epub 2020 Sep 3.

本文引用的文献

1
Validation of a self-report comorbidity questionnaire for multiple sclerosis.多发性硬化症自报共病问卷的验证。
Neuroepidemiology. 2010 Aug;35(2):83-90. doi: 10.1159/000311013. Epub 2010 Jun 15.
2
The changing demographic pattern of multiple sclerosis epidemiology.多发性硬化症流行病学的人口统计学变化模式。
Lancet Neurol. 2010 May;9(5):520-32. doi: 10.1016/S1474-4422(10)70064-8.
3
Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis.血管合并症与多发性硬化症中更快的残疾进展有关。
Neurology. 2010 Mar 30;74(13):1041-7. doi: 10.1212/WNL.0b013e3181d6b125.
4
Body size and risk of MS in two cohorts of US women.美国女性两个队列中的体型与多发性硬化症风险
Neurology. 2009 Nov 10;73(19):1543-50. doi: 10.1212/WNL.0b013e3181c0d6e0.
5
Smoking and disease progression in multiple sclerosis.吸烟与多发性硬化症的疾病进展
Arch Neurol. 2009 Jul;66(7):858-64. doi: 10.1001/archneurol.2009.122.
6
Long-term effect of comorbidity on the course of physical functioning in patients after stroke and with multiple sclerosis.共病对中风患者和多发性硬化症患者身体功能进程的长期影响。
J Rehabil Med. 2009 Apr;41(5):322-6. doi: 10.2340/16501977-0335.
7
Comorbidity delays diagnosis and increases disability at diagnosis in MS.合并症会延迟多发性硬化症的诊断,并增加确诊时的残疾程度。
Neurology. 2009 Jan 13;72(2):117-24. doi: 10.1212/01.wnl.0000333252.78173.5f. Epub 2008 Oct 29.
8
Comorbidity, socioeconomic status and multiple sclerosis.共病、社会经济地位与多发性硬化症
Mult Scler. 2008 Sep;14(8):1091-8. doi: 10.1177/1352458508092263.
9
Influence of co-morbid generalized anxiety disorder, panic disorder and personality disorders on the outcome of cognitive behavioural treatment of obsessive-compulsive disorder.共病广泛性焦虑障碍、惊恐障碍和人格障碍对强迫症认知行为治疗结果的影响。
Cogn Behav Ther. 2007;36(3):145-55. doi: 10.1080/16506070701259374.
10
Validation of the NARCOMS registry: diagnosis.NARCOMS注册库的验证:诊断
Mult Scler. 2007 Jul;13(6):770-5. doi: 10.1177/1352458506075031. Epub 2007 Mar 15.

合并症与 MS 的临床特征之间的关系。

Association between comorbidity and clinical characteristics of MS.

机构信息

Department of Medicine, University of Manitoba, Winnipeg, Canada.

出版信息

Acta Neurol Scand. 2011 Aug;124(2):135-41. doi: 10.1111/j.1600-0404.2010.01436.x. Epub 2010 Sep 29.

DOI:10.1111/j.1600-0404.2010.01436.x
PMID:20880264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3394540/
Abstract

BACKGROUND

Comorbidity may be associated with the clinical phenotype of disease and may affect prognostication and treatment decisions. Using the North American Research Committee on Multiple Sclerosis Registry, we described comorbidities present at onset and diagnosis of multiple sclerosis (MS) and examined whether comorbidities present at onset were associated with clinical course or age of MS symptom onset.

METHODS

In 2006, 8983 participants reported their physical and mental comorbidities; smoking status; height; and past and present weight. We compared clinical course at onset and age of symptom onset by comorbidity status.

RESULTS

At MS onset, a substantial proportion of participants had physical (24%) or mental (8.4%) comorbidities. The mean (SD) age of MS onset was 31.2 (9.0) years. Vascular, autoimmune, cancer, visual, and musculoskeletal comorbidities were associated with a later age of symptom onset. Among men and women, the odds of a relapsing course at onset were increased if mental comorbidities (OR 1.48; 1.08-2.01) were present at symptom onset. In women, gastrointestinal comorbidities (OR 1.78; 1.25-2.52) and obesity (OR 2.08 1.53-2.82) at MS onset were also associated with a relapsing course at onset.

CONCLUSIONS

Comorbidity is frequently present at onset of MS and is associated with differences in clinical characteristics.

摘要

背景

合并症可能与疾病的临床表型有关,并可能影响预后和治疗决策。利用北美多发性硬化症研究委员会的登记资料,我们描述了多发性硬化症(MS)发病和诊断时存在的合并症,并探讨了发病时存在的合并症是否与临床病程或 MS 症状发作年龄有关。

方法

2006 年,8983 名参与者报告了他们的身体和精神合并症、吸烟状况、身高以及过去和现在的体重。我们根据合并症状况比较了发病时的临床病程和发病年龄。

结果

在 MS 发病时,相当一部分参与者存在身体(24%)或精神(8.4%)合并症。MS 发病的平均(标准差)年龄为 31.2(9.0)岁。血管、自身免疫、癌症、视力和肌肉骨骼合并症与症状发作年龄较晚有关。在男性和女性中,如果在症状发作时存在精神合并症(OR 1.48;1.08-2.01),则发病时出现复发病程的可能性增加。在女性中,MS 发病时存在胃肠道合并症(OR 1.78;1.25-2.52)和肥胖(OR 2.08;1.53-2.82)也与发病时出现复发病程有关。

结论

合并症在 MS 发病时经常存在,并与临床特征的差异有关。